United States · 
Who invested in Medefy?
Medefy's investors include Mercury Fund, Advantage Capital and i2E.
201320152017201920212023
$40KSeed$15MSeries AUnited States · Series A startup
Who invested in Medefy
2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$15Mraised across 2 rounds since 2013, from 2 sources
$40KSeed$15MSeries A
- Latest round
- Series A, $15MDec 2023
- Step-upi
- 382.5×
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Seed, $40K Jan 2013
- Biggest round
- $15M Series A · Dec 2023
- Between rounds
- 10.9 years from the last two
The rounds
- Dec 2023Series A$15M2 new
Source recordedSEC filing: $11M sold, first sale Sept 2023
- Jan 2013
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list Medefy as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Medefy
How much has Medefy raised?
Medefy has raised $15M across 2 rounds since 2013.
When did Medefy last raise?
Medefy's most recent round was a Series A of $15M in Dec 2023.
What was Medefy's biggest round?
Its most recent round, $15M in Dec 2023, is also its largest on record.
Who backed Medefy first?
Medefy's first round on record, in Jan 2013, was backed by i2E.
What stage is Medefy at?
Medefy's latest named round is a Series A, in Dec 2023.
Where is Medefy based?
Medefy is based in the United States.
Companies like Medefy
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.